Arkolith/Insider Trading/AMLX/Form 4

Firestone Karen

DirectorAmylyx Pharmaceuticals, Inc. (AMLX) · full profile →Form 4 · filed May 26, 2026
Net Buying
Open-Market Buys
$51K
Open-Market Sells
$0
Net Open-Market Flow
$51K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 21, 2026Buy(P)4K$13.51$51K67K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-239216) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML